A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

628

Participants

Timeline

Start Date

May 27, 2019

Primary Completion Date

January 20, 2021

Study Completion Date

January 20, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

DRUG

Insulin Glargine

Administered SC

DRUG

Insulin Degludec

Administered SC

Trial Locations (41)

44650

Unidad de patologia Clinica, Guadalajara

45116

Centro de Inv. Medica de Occidente, SC, Zapopan

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey

66465

Unidad Médica para la Salud Integral, San Nicolás de los Garza

100730

Beijing Peking Union Medical College Hospital, Beijing

101200

Beijing Pinggu District Hospital, Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

116033

Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian

130033

China-Japan Union Hospital, CJUH., Changchun

136000

Siping Central People's Hospital, Siping

150001

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

161006

The First Hospital of Qiqihar, Qiqihar

200062

Shanghai Putuo District Center Hospital, Shanghai

210009

Zhongda Hospital Southeast University, Nanjing

210012

The First Hospital of Nanjing, Nanjing

211100

Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

213003

Changzhou No.2 People's Hospital, Changzhou

214400

The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin

250013

Jinan Central Hospital, Jinan

300052

Tianjin Medical University General Hospital, Tianjin

330009

The Third Hospital of Nanchang, Nanchang

337000

Pingxiang People's Hospital, Pingxiang

350001

Fujian Medical University Union Hospital, Fuzhou

400014

Chongqing General Hospital, Chongqing

414000

The First People's Hospital of Yueyang, Yueyang

424300

Chenzhou NO.1 People's Hospital, Chenzhou

430000

Wuhan Pu'ai Hospital, Wuhan

443003

Yichang Central People's Hospital, Yichang

471003

The First Affiliated Hospital of Henan University of Science &Technology, Luoyang

810001

Qinghai University Affiliated Hospital, Xining

C1120AAC

Centro Médico Viamonte, Buenos Aires

C1056ABJ

Centro de Investigaciones Metabólicas (CINME), CABA

X5008HHW

Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC, Córdoba

061000

Cangzhou People's Hospital, Cangzhou

066000

The First Hospital of Qinhuangdao, Qinhuangdao Shi

010017

Inner Mongolia People's Hospital, Hohhot

Unknown

Shanghai 6th people's hospital, Shanghai

The Central Hospital of Wuhan, Wuhan

The First Affiliated Hospital of Xi'an Medical University, Xi’an

054031

Xingtai People's Hospital, Xingtai

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03952143 - A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes | Biotech Hunter | Biotech Hunter